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A multicenter study of IgA nephropathy in children. A report
of the Southwest Pediatric Nephrology Study Group1
A multicenter study of IgA nephropathy in children. A report of the
Southwest Pediatric Nephrotogy Study Group. Clinical and pathologic
features of IgA nephropathy were evaluated in 62 children (age range, 4
to 18 years; 46 boys, 16 girls) in a collaborative study carried out by
members of the Southwest Pediatric Nephrology Study Group
(SPNSG). Microscopic hematuria was present in all of the patients prior
to renal biopsy and was associated with gross hematuria in 85%,
proteinuria ( 2+) in 48%, hypertension in 6%, and depressed GFR in
25% of the patients. Renal biopsy specimens were reviewed and
classified into three groups on the basis of light microscopy (LM): (1)
normal glomeruli (16 patients), (2) mesangial hypercellularity (25 pa-
tients), and (3) focal and segmental proliferative and/or scierosing
glomerulonephritis (21 patients). Tubulo-interstitial changes, which
were present in 56% of the biopsy specimens, showed no correlation
with the duration of clinical disease. Peripheral glomerular capillary
wall changes shown by electron microscopy (EM) were present in 40%
of the biopsy specimens and were associated with more severe glomeru-
lar changes revealed by LM. Proteinuria and episodes of gross hematu-
na were associated with more severe histologic changes (group 3) and
peripheral capillary wall changes demonstrated by EM. Mild patterns of
glomerular damage (groups 1 and 2) were associated with female sex.
The studies show that evidence of tubulo-interstitial damage and
peripheral glomerular capillary wall changes are not uncommon in
children with IgA nephropathy and suggest that these features may be
harbingers of a more serious prognosis than previously thought.
Etude multicentrique de Ia nephropathie a IgA chez des enfants. Le
rapport du Southwest Pediatric Nephrologic Study Group. Les caractér-
istiques cliniques et pathologiques de Ia néphropathie a IgA ont été
étudiées chez 62 enfants (4 a 18 ans; 46 garcons, 16 flIes) dans une
étude cooperative faite par les membres du Southwest Pediatric Neph-
rologic Study Group (SPNSG). Une hématurie microscopique était
présente chez tous les malades avant Ia biopsie rénale et était associée a
une hématurie macroscopique chez 85%, a une protdinurie ( 2+) chez
48%, a une hypertension chez 6%, et a une diminution de GFR chez
25% des malades. Les biopsies rénales ont été revues et classées en
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trois groupes sur la base de Ia microscopie optique (LM): (1) glomérules
normaux (16 malades), (2) hypercellularité mésangiale (25 malades), et
(3) hypercellularite mesangiale avec glomérulonéphrite focale segmen-
taire proliferative et/ou sclérosante surajoutée (21 malades). Les modifi-
cations tubulo-interstitielles, qui étaient présentes dans 56% des biop-
sies, n'étaient pas corrélées avec Ia durée de Ia maladie clinique. Des
modifications de paroi du capillaire glomerulaire péripherique en mi-
croscopie electronique (EM) étaient présentes dans 40% des biopsies et
étaient associées avec des modifications glomérulaires plus sévères en
LM. La protéinurie et les episodes d'hématurie macroscopique étaient
associés avec des modifications histologiques plus sévéres (groupe 3) et
des modifications de Ia paroi capillaire peripherique en EM. Des
aspects modérés de lesion glomerulaire (groupes 1 et 2) étaient associés
chez les filles. Ces etudes montrent que l'existence de lesions tubulo-
interstitielles et de modifications de Ia paroi capillaire glomerulaire
péripherique ne sont pas rares chez les enfants atteints de néphropathie
a IgA et suggerent que ces caractéristiques pOurraient être les prémices
d'un pronostic plus sérieux qu'on le pensait auparavant.
The association of idiopathic glomerulonephritis and diffuse
mesangial deposition of immunoglobulin A (IgA) was first
described by Berger and Hinglais in 1968 [1]. Since that time, a
large number of reports have examined the natural history of
this disorder in adults [2—291 and children [9, 30—35], but the
results have been conflicting. In most pediatric studies the
prognosis has appeared good, but the number of patients
available for study in any one center has been small. The
present study evaluates initial clinical and pathologic features of
IgA nephropathy in a large sample of children Who were
observed by members of the Southwest Pediatric Nephrology
Study Group (SPNSG)'.
The aims of the study were (1) to perform a retrospective
analysis of the initial clinical course of children and adolescents
with idiopathic glomerulonephritis associated with diffuse mes-
angial deposition of IgA; (2) to undertake detailed pathologic
review of renal biopsy specimens in all the patients; and, (3) to
analyze multiple clinical and pathologic features, seeking early
clinico-pathologic correlations that may subsequently assist in
the prediction of clinical outcome in individual patients. We
also report herein our observations of these children during a
limited follow-up period, although at the present time this
information is insufficient to predict the clinical course.
Methods
Clinical and laboratory studies. Patients were considered for
entry into the study on the basis of a renal biopsy specimen
demonstrating mesangial IgA deposition, but they were exclud-
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Table 1. Clinical and pathologic features assessed in patients with IgA
nephropathy
Pathologic
(1) Pattern of glomerular inju-
ry by light microscopy
(2) Presence/absence of tubu-
lointerstitial damage
(3) Severity of mesangial igA
deposition
(4) Presence/absence of IgG
(5) Presence/absence of 1gM
(6) Presence/absence of C1
(7) Presence/absence of fi-
brin(ogen) related
antigen
(8) Presence/absence of
glomerular capillary
wall staining
(9) Presence/absence of pe-
ripheral capillary wall
changes by EM (depos-
its, splitting, thinning)
(10) Presence/absence of focal
global sclerosis
ed if clinical or serologic evidence of systemic lupus erythema-
tosus, chronic liver disease, or Henoch-Schonlein purpura was
present. Patients were also excluded if the pathologic material
was not adequate for examination by light microscopy and
immunofluorescence. The presence or absence of complement
components or immunoglobulins G or M were not included in
the pathologic criteria for entry. Patients were entered into the
study only after review of their biopsy specimens by at least
three pathologists of the SPNSG. The pathologic grading sys-
tem was determined at a combined review session attended by
ten of the participating SPNSG pathologists.
There were no specific clinical criteria for entry apart from
the exclusions previously listed. As such, the patient population
that was selected for study reflects the variety of opinions
among pediatric nephrologists regarding the necessity for renal
biopsy in children presenting with "idiopathic" hematuria, with
or without proteinuria. The data collected are not, therefore,
intended to be representative of a random sample of patients
with any particular clinical syndrome. On the contrary, the
clinical information was only collected after the acceptance of a
patient into the study on the basis of a positive renal biopsy
specimen. Clinical features were obtained by careful retrospec-
tive study of the hospital records of each patient. This was
performed by individual SPNSG physicians in each participat-
ing center using a detailed questionnaire. The clinical features
that were assessed are depicted in Table 1.
Some variation in laboratory studies between patients in
different participating centers was found as a result of the
retrospective nature of the study. Most of the patients had both
quantitative and semi-quantitative assessment of protein excre-
tion and GFR, but this was not universal and even when present
was not based on the same method used in all patients.
However, good agreement existed between the various meth-
ods used in individual patients, suggesting that the lack of
standardized quantitative measurements did not significantly
impair the initial clinical assessment of these patients. This lack
of conformity in the initial laboratory evaluation represents a
limitation of many retrospective multicenter studies such as
ours. In interpreting and comparing the laboratory data in
patients from different centers, we therefore adopted the fol-
lowing guidelines: (1) Urine protein excretion was expressed as
o to 4+ using the dipstick and/or sulphosalicylic acid methods.
(2) GFR (ml/min/l .73 m) was estimated as inulin, creatinine, or
sodium iothalomate (Glofil) clearance when one of these proce-
dures was performed but otherwise was calculated from the
formula [36]:
GFR (mllmin/i .73 m2) = 0.55 body length (cm)
serum creatinine (mg/dl)
The GFR (ml/min/l .73 m2) of each patient was then placed into
one of the following categories: normal (more than 90); mild
decrease (60 to 90); moderate decrease (30 to 60) or severe
decrease (less than 30) for comparative analysis.
Pathologic studies. All renal biopsy specimens from patients
documented to have predominant/codominant glomerular mes-
angial staining with antisera to IgA (as compared to other
immunoreactants) were reviewed by the pathologists from the
submitting institutions. The renal tissue samples had been fixed
in Duboscq-Brasil, Zenker's or 10% formalin solution, embed-
ded in either paraffin or plastic, and cut into thin sections by
routine methods at each participating institution. Sections were
stained with hematoxylin and eosin, periodic acid-Schiff, and
usually with silver methenamine, and Masson's Trichrome. All
were examined by the institutional pathologists in conjunction
with the original diagnostic biopsy report, Selected slides
(range, ito 16; average 4) were then reexamined by a panel of at
least two other SPNSG pathologists to arrive at a consensus on
the classification of each biopsy specimen to one of the three
histopathologic subgroups of IgA nephropathy described be-
low. Final determination of histologic classification and place-
ment of each biopsy specimen was provided after intensive
review of all biopsy specimens. Acceptable biopsy specimens
included those renal tissue samples with predominant/codomi-
nant glomerular mesangial igA deposition in addition to ade-
quate material for light microscopic (LM) examination (range, 1
to >100; average, 21 glomeruli).
Renal biopsy specimens from 62 patients were studied by LM
and assessed with respect to the severity of individual histo-
pathologic features in the glomeruli, tubules, interstitium, and
arteries. Abnormalities were then graded semiquantitatively on
a 0 to 4+ scale according to methods previously described by
Pirani, Salinas-Madrigal, and Koss [371. In the glomeruli,
particular attention was given to mesangial cellularity and the
amount of mesangial matrix, the presence of sclerosis, necrosis,
or crescents, and thickening of the glomerular basement mem-
brane. In addition, the percent of glomeruli involved was
determined. Other histopathologic features evaluated were tu-
bular atrophy, degeneration, dilatation and casts, presence of
intratubular erythrocytes, interstitial inflammation, edema, fi-
brosis, and arterial and arteriolar sclerosis.
Immunofluorescence (IF) findings on the 62 biopsy speci-
mens were obtained from the submitting pathologist and the
original biopsy report (sometimes accompanied by photograph-
ic documentation). Specimens for IF were snap-frozen and
stained by the direct method using fluoresceinated antisera
monospecific for IgG, 1gM, IgA, and C3, and, in some in-
stances, for CIq, C4, C5, fibrin(ogen)-related antigen, proper-
din, albumin, IgE, and alpha-2-microglobulin. Sources of the
antisera varied, but the majority of the submitting institutions
Clinical
(I) Age at clinical presentation
(2) Age at renal biopsy
(3) Period between presenta-
tion and biopsy, months
(4) Period of follow-up since
presentation, months(5) Sex(6) Race
(7) Blood pressure
(8) Presence/absence of gross
hematuria
(9) Severity of proteinuria
(10) Glomerular filtration rate
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Fig. 1. (Top, left) Group 1. Light micrograph showing a normal glomerulus. (hematoxylin and eosin, x340) Fig. 2. (Middle, left) Group 2. Light ml-
crograph showing a glomerulus with an increase in the number of cells (three or more) in the mesangial regions distant from the vascular pole. (he-
matoxylin and eosin, x340) Fig. 3. (Bottom, left) Group 3. Light micrograph showing a glomerulus with two segmental regions of proliferation and
synechiae formation. (hematoxylin and eosin, x340) Fig. 4. (Top, right) Group 3. Light micrograph of a glomerulus with a segmental region of
glomerular tuft hypercellularity and contiguous crescent formation. (PAS stain, ><340) Fig. 5. (Middle, right) Group 3. Light micrograph of a
glomerulus showing segmental sclerosis with collapse of several f the glomerular capillary lumens. (PAS stain, x 340) Fig. 6. (Bottom, right) Light
micrograph showing tubular atrophy and interstitial fibrosis and inflammation. (methenamine silver stain, x 180)
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tuft; (3) focal, a lesion affecting less than 50%of the glomeruli in
the specimen,
Tubulo-interstitial changes, including tubular atrophy, tubu-
lar casts, and interstitial fibrosis or inflammation were identified
as a separate subgroup (Fig. 6).
Statistical methods. Correlations were sought within and
between the ten clinical and ten pathologic features listed in
Table 1. The statistical methods utilized were x2 contingency
table analysis or Fisher's exact probability test where
appropriate.
Results
Fig. 7. Distribution of patients with IgA nephropathy according to sex
and age at clinical presentation.
utilized reagents from Meloy Lab, Inc., Springfield, Virginia.
One to five glomeruli were studied and particular attention was
given to the presence or absence of immunoreactants, intensity
of IF staining and location of the staining.
Electron microscopic (EM) findings were obtained and com-
piled from selected prints and the accompanying diagnostic
reports. EM studies of the glomeruli were performed on 58 of
the 62 patients. Tissue samples were processed for EM by each
of the submitting institutions according to presently accepted
techniques. Fixatives included glutaraldehyde, one-half
strength Karnovsky, and Carson's formalin. The tissues were
generally postfixed in osmium tetroxide and embedded in epon.
Ultrathin sections, cut on ultramicrotomes (Sorval MT2 or
LKB3) with a diamond knife, were stained usually with aque-
ous uranyl acetate and lead citrate and were examined ultra-
structurally in a variety of electron microscopes (Philips 201,
Siemens 101, Zeiss, or AEI). Particular attention was given to
the presence or absence of discrete glomerular electron-dense
"immune-type" deposits (mesangial or capillary wall) and other
glomerular basement membrane changes.
Histologic definitions. The term "group 1", or essentially
normal glomeruli, was used when all the glomeruli were histo-
logically normal or only slightly modified (Fig. I). The presence
of occasional globally sclerotic glomeruli or tubulo-interstitial
changes did not remove a biopsy specimen from this category.
"Group 2" biopsy specimens showed mesangial proliferation,
that is, increased cellularity in the glomerular mesangial re-
gions, as defined by the WHO Committee on Classification and
Nomenclature of Renal Disease [38] [three or more cells per
peripheral mesangial area in a thin light microscopic section
(Fig. 2)]. Evaluation of glomerular hypercellularity included
allowances for the variation of the thickness of the individual
sections, and cellularity was judged from the peripheral por-
tions of the glomerulus. "Group 3" biopsy specimens exhibited
focal and segmental proliferative changes, associated with
segmental areas of necrosis, synechiae formation (Fig. 3),
crescent formation (Fig. 4), or glomerular capillary wall col-
lapse and sclerosis (Fig. 5).
The following definitions apply to the distribution of lesions:
(1) global, a lesion affecting the entirety of the glomerulus; (2)
segmental, a lesion affecting only a portion of the glomerular
The age and sex of the 62 children accepted into the study are
depicted in Figure 7. Sixty-five percent of the children were
between 6 and 11 years of age at clinical presentation and 74%
were boys.
Clinical and laboratory studies
Prior to renal biopsy. All 62 patients had microscopic hema-
tuna and in 85% at least one episode of gross hematuria was
noted prior to renal biopsy. One additional patient who present-
ed with microscopic hematuria prior to biopsy subsequently
had two episodes of gross hematuria. Nephrotic syndrome was
noted in one patient at the initial presentation and had been
present in two other patients many years before the onset of
hematuria. The relationship between the nephrotic syndrome
and subsequent finding of IgA nephropathy in these patients is
unclear. Proteinuria ( 2+) was recorded in 19 out of 45
patients (42%) at the time of initial presentation to the patient's
physician and in 30 out of 62 patients (48%) on at least one
occasion prior to renal biopsy. Serum IgA levels were measured
in nine patients and found to be above the upper limit of age-
related normal levels in three of these. Hypertension was noted
in four patients and depressed values for GFR were present in
16 patients on at least one occasion prior to biopsy—the
decrease was mild in II, moderate in 4, and severe in 1. Renal
biopsies were performed after variable periods of clinical obser-
vation, ranging from a few days to 7.5 years with a mean of 15
months.
Subsequent clinical course. The total period of follow-up of
the patients from clinical detection of renal disease varies from
1 month to 13 years (mean duration, 3 years 4 months), with a
mean follow-up from the biopsy of 25 months. In 16 children
followed for 5 or more years, seven have proteinuria (44%), one
is hypertensive (6%), and three have decreased GFR (19%),
which is mild in one patient, moderate in another, and has led to
endstage renal disease in the third patient. The latter patient is a
boy who presented with an episode of gross hematunia, protein-
uria, and transient hypertension at 5 years. His renal function
was initially normal and his clinical features resolved after I
week. He was seen again 1 year later with a second episode of
gross hematuria following an upper respiratory infection. A
renal biopsy, performed at that time, revealed focal glomerulo-
nephritis associated with mesangial IgA deposition (group 3),
and EM studies showed focal thinning and lamination in the
basement membrane of peripheral glomerular capillary loops.
The patient then was lost to follow-up but reappeared 4 years
later with advanced renal failure (serum creatinine 10.8 mg/dl),
hypertension, and proteinuria and, on repeat biopsy, was found
to have, persistent mesangial igA deposition associated with
Mean age
Males 9.6 years
Females 6.0 years
Overall 9.2 years
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
A9e, years
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Fig. 8. (Left) Immunofluorescent micrograph. The glomerular mesangial regions contain abundant deposits of IgA with little peripheral capillary
wall staining. (immunofluorescence, x450). Fig. 9. (Right) Immunofluorescent micrograph. A portion of the glomerular tuft shows paramesangial
deposits of IgA just beneath the glomerular basement membrane overlying the mesangium. (immunofluorescence, x600)
widespread crescenteric glomerulonephritis (100% of glomeruli
involved). Since that time, he has undergone successful trans-
plantation. No biopsy of the transplanted kidney has been
performed. In an additional 23 patients in whom the period of
follow-up has been 2 to 5 years, six have proteinuria (23%),
three have mild decreases in GFR (11%), and one is hyperten-
sive (4%).
Pathologic studies. Renal biopsy specimens were classified
into the three patterns described: group 1, 16 patients; group 2,
25 patients; and group 3, 21 patients. Tubulo-interstitial changes
were present in 56% and were slightly more likely found in
association with the more severe glomerular changes (38% in
group 1; 60% in group 2; 70% in group 3), but this was not
statistically significant. Erythrocytes in the tubules (23% of all
patients) were noted in each of the three glomerular patterns,
but this finding was not related significantly to the severity of
the glomerular changes or any clinical finding. Mild thickening
of the afferent arterioles was noted in one patient who was not
hypertensive. Global glomeruloscierosis (defined as greater
than 10% of glomeruli showing global sclerosis) was noted in
10% of the patients; it was more commonly noted in the biopsy
specimens within group 3, although this relationship did not
reach statistical significance.
IgA immunofluorescence studies revealed mesangial deposi-
tion in all patients (Fig. 8). Glomerular IgA staining was
interpreted initially as being peripheral in 23% of the patients,
but on review it was thought to represent paramesangial rather
than peripheral glomerular capillary wall staining (Fig. 9).
Tubular basement membrane staining was noted in four patients
(IgA alone in three, C5 in one) but was not associated with
histologic evidence of tubulo-interstitial damage. Arteriolar
staining was noted in five patients (C3 in all, C4 in three, and
IgA with 1gM in one), none of whom had tubular basement
membrane staining or hypertension. IgG, usually of lesser
intensity, was noted in 77% of those patients in whom it was
sought (N = 57), 1gM in 22% (N = 43), C3 in 77% (N = 58), C4
in 24% (N = 25), Clq in 15% (N = 20), properdin 29% (N = 14)
and fibrin(ogen)-related antigen in 45% (N = 37). There was no
correlation noted between the presence, intensity, or location
of immunofluorescence staining and the various glomerular
patterns or the presence of tubulo-interstitial damage. There
was no relationship between Clq, C4, and 1gM deposition.
By EM, no electron-dense deposits were noted within the
mesangial cells but 56 out of 58 biopsy specimens exhibited
discrete deposits in the glomerular paramesangial areas, most
commonly in the mesangial matrix just beneath the glomerular
basement membrane (Fig. 10). One of the patients without
obvious mesangial deposits had a group 1 pattern whereas the
other showed a group 2 pattern. The mesangial deposits were of
varying electron density, sometimes granular and often varied
in size. The mesangial deposits present in regions of severe
glomerulosclerosis were often less discrete and electron dense
than the mesangial deposits in regions of better glomerular
preservation. The quantity of mesangial deposits varied some-
what from region to region within the glomerulus. Elevation of
the glomerular basement membrane over the large paramesan-
gial deposits (so-called "arc de cercle") was only rarely noted.
Collagen was not detected in the mesangial regions. Peripheral
glomerular capillary wall deposits were noted in subendothelial
regions (16%), subepithelial regions (10%), and intramembra-
nous regions (9%) (Fig. 11). These glomerular deposits were
granular and similar to those noted in the mesangial regions but
were usually few in number, small in size, and occurred in too
few patients to determine any relationship between the pres-
ence of deposits and any clinical finding. Although noted
slightly more often in group 3 than groups 1 and 2, the small
numbers of patients with these changes rendered pathologic
correlations impossible. The small subendothelial deposits were
situated usually near the mesangial regions but were occasional-
ly along the periphery of the glomerular capillary wall. No
definite deposits were noted by electron microscopy in the
basal lamina of Bowman's capsule or in any extraglomerular
structure studied.
Other electron microscopic changes in the glomeruli included
focal and segmental thinning, rarefaction, or mild lamination of
the lamina densa (Fig. 12), and mild to severe irregularity of the
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Fig. 10. (Top, left) Electronmicrograph. A segment of glomerular tuft showing abundant electron dense deposits in a mesangial region.
(electronmicrograph, )< 12,000) Fig. 11. (Bottom, left) Elecironmicrograph. This peripheral segment of a glomerular capillary loop contains a
number of discrete subendothelial and subepithelial electron dense deposits. In Bowman's space on the right, portions of two red blood cells are
noted. (electronmicrograph, x 18,000) Fig. 12. (Top, right) Electronmicrograph. A segment of the glomerular tuft showing two peripheral
glomerular capillary walls. The glomerular basement membrane on the left is markedly thinned and has an irregular inner and outer contour. The
glomerular basement membrane on the right is essentially normal in contour, texture, and thickness. (electronmicrograph, x6000) Fig. 13. (Bottom,
right) Electronmicrograph. This segment of a peripheral glomerular capillary wall shows irregularity in the Contour, texture, and thickness of the
glomerular basement membrane. Microvillus transformation and effacement of the visceral epithelial cells is noted. (electronmicrograph, x4000)
glomerular capillary wall contour with widening of the lamina
rara interna by subendothelial electron-lucent material (Fig.
13). These abnormalities in the contour, texture, and thickness
of the peripheral glomerular capillary walls were noted in 40%
of the biopsy specimens and were present in well preserved
regions of the glomeruli. apparently distant from areas of
glomerular capillary lumen collapse and severe sclerosis. They
were noted in none of group 1 biopsy specimens, 25% of group 2
biopsy specimens, and 90% of the group 3 biopsy specimens.
Most of the patients with group 2 biopsy specimens showing
capillary wall changes had tubulo-interstitial changes (6 out of
7) and a fairly severe degree of mesangial hypercellularity.
In addition to the pathologic changes noted above, there were
nonspecific findings such as mild to moderate hypertrophy of
the visceral epithelial cells with focal effacement of their foot
processes and microvillus transformation. These changes oc-
curred most frequently in glomerular capillary walls showing
glomerular basement membrane thinning and lamination.
Pathologic correlations. A highly significant correlation (P <
0.001) was found between the severe pattern of glomerular
damage defined histologically (group 3) and the presence of
peripheral glomerular capillary wall thinning, splitting, and
lamination noted by electron microscopy. No statistically sig-
nificant associations were found between any other pathologic
features.
Clinico-pathologic correlations. The relationship between
the three glomerular patterns and the age of the patients at the
time of renal biopsy is depicted in Figure 14. No correlation
could be demonstrated between age and the severity of the
glomerular lesion (P> 0.05). Similarly, no correlation between
gar i-r -
r'tsu
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the duration of disease prior to renal biopsy and severity of
glomerular pattern could be demonstrated (P > 0.05). In
addition, no significant association was found between the
incidence of tubulo-interstitial damage and the period between
presentation and biopsy (P > 0.05), although there was a
tendency for more tubulo-interstitial damage to be present in
patients biopsied early in the clinical course. The time interval
between presentation and biopsy was significantly longer in
patients with focal global sclerosis (>10% of glomeruli)—mean
duration 35 months versus 15 months in other patients.
Comparison of pathologic features in the two sexes revealed
that girls had a greater incidence (P = 0.01) of mild glomerular
lesions (group 1) by light microscopy but were found to have a
higher incidence (P = 0.005) of capillary wall staining by
immunofluorescence. This has subsequently been interpreted
to represent paramesangial staining, as discussed above. De-
spite these correlations between patient sex and pathologic
features, there was no difference in the two sexes between
GFR, proteinuria, and incidence of hypertension during the
limited period of follow-up. No correlation was found between
patient race and any clinical or pathologic finding.
A significant correlation was found between proteinuria at
the time of biopsy and the following pathologic features: (1)
group 3 glomerular pattern (P = 0.03); (2) peripheral glomerular
capillary wall changes by electron microscopy (that is, splitting,
thinning, rarefaction, irregular contour and electron dense
deposits, P = 0.003), and (3) the presence of fibrin(ogen) related
antigen demonstrated by immunofluorescence (P = 0.02). Pro-
teinuria was persistent in all four patients found to have focal
segmental sclerosis although none of these have shown overt
nephrotic syndrome. Three of the patients have been followed
for more than 3 years beyond the time of biopsy. Absence of
episodes of gross hematuria (15% of the patients) was found to
be associated with more benign histopathologic patterns, that
is, groups 1 and 2 (P = 0.02) and absence of glomerular capillary
wall changes (P = 0.05).
Discussion
Many reports of glomerulonephritis associated with mesan-
gial deposition of IgA have been published since the original
report of IgA-IgG nephritis by Berger and Hinglais [1]. The
apparent incidence of this disorder has varied in studies from
different countries, and this has led to the theory that the
geographic distribution of cases may be linked to genetic
factors. Based on the studies published to date, it would appear
that IgA nephropathy is one of the most common forms of
glomerular disease in France [2—4, 8, 311, Spain [391, Italy [5,
23, 27], Japan [19, 21, 28, 29, 40—42], Singapore [43], and
Australia [10, 44]. In these countries, the incidence has ranged
from 11.7 to 43.3% of renal biopsies. Much lower rates of
incidence have been documented in the United States [7, 9,12,
13, 16, 45, 46], England [11], Hungary [20], Canada [15, 171,
Ireland [24], China [47], and the Netherlands [161, with the
incidence rate ranging from 2 to 8.5% in these studies.
Berger suggested that the higher reported incidence of this
disorder in certain countries compared to others may reflect the
practice of routine annual urinalysis in the countries with high
incidence rates [48]. Certainly, there is considerable variation in
the incidence of gross hernaturia (21% to 100%) in the patients
that have been reported. This variation is particularly promi-
nent when adult and pediatric studies are compared. In our
study, 62 pediatric patients characterized by the pathologic
picture of predominant/codominant mesangial IgA deposition
on renal biopsy showed a range of clinical features, including
persistent microscopic hematuria with or without episodes of
gross hematuria and a variable presence of proteinuria. We
included patients in whom immunoglobulins other than IgA and
IgG were present since there is currently no agreement as to
whether or not their presence requires them to be regarded as
separate diseases. A recent paper by Clarkson et al [49] reports
that increasing 1gM deposition may occur with decreasing
amounts of IgA and IgG. The finding of 1gM deposits in
association with segmental sclerotic lesions lends support to the
postulate that 1gM deposition may occur as a secondary process
in areas of sclerosis. Our study also includes patients in whom
extra-mesangial deposition of immunoglobulins and electron
microscopic evidence of peripheral glomerular capillary wall
changes are present.
There is considerable controversy regarding the mechanism
by which IgA produces glomerular damage and clinical disease.
It has been proposed that aggregated IgA in the glomerular
mesangium may activate the complement system via the alter-
nate pathway [9, 11, 12, 14, 15, 18, 50—521 since attempts to
demonstrate Clq and C4 in the glomeruli or skin of patients
with IgA nephropathy have usually been negative [14, 39, 51,
52]. Further support for the alternate-pathway mechanism has
been claimed by the finding of properdin in association with C3
in many patients in whom this has been sought [12, 15, 50]. In
our study, Clq and C4 were demonstrated in 24 and 15%,
respectively, whereas properdin was apparent in 29% of biopsy
specimens in which they were sought. It should be noted,
however, that there was no standardization of antisera used in
the various centers performing these immunofluorescent
studies.
A general agreement now appears that serum levels of IgA
increase in a significant proportion of patients with IgA
nephropathy [12—16, 26, 28, 49, 53, 54]. The relationship
between elevated levels of igA and glomerular disease is,
however, unclear. Attempts to define a relationship between
serum IgA levels and the deterioration of renal function have
been unsuccessful in most studies. In addition, failure to show
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any improvement in clinical and histologic findings in patients
with IgA nephropathy in whom serum IgA levels were reduced
by phenytoin suggests that the serum IgA level per se is not of
great significance in the development of this disease [49]. In our
study, serum IgA levels were measured infrequently and only
one out of nine patients had a level greater than 350 mg/dl.
However, levels were increased above age-matched normal
limits in three out of nine patients.
Since the original description of IgA nephropathy, a number
of studies have attempted to correlate initial clinical and patho-
logic findings with the subsequent course of disease. Hara et al
[211 evaluated the ultrastructural significance of glomerular
subendothelial deposits in terms of the overall disease expres-
sion. Patients with subendothelial deposits were found to have
increased mesangial cells and matrix and, on repeat biopsy,
showed increased thickening of the mesangial matrix with time.
Proteinuria and renal insufficiency were also more common in
patients with subendothelial deposits. Correlation between
more extensive pathologic features and severe clinical manifes-
tations were also documented by Levy et a! [311 in a study of 36
children, four of whom had persistent proteinuria. In a retro-
spective study of IgA nephropathy, van der Peet et a! in the
Netherlands [161 evaluated patients with decreased renal func-
tion compared to patients who maintained normal renal func-
tion. The group which showed deterioration were ten years
older and had a follow-up period that was 20 months longer in
duration. In addition, this group showed more proteinuria,
worse hypertension, and more marked histologic findings on
renal biopsy. Barbiano di Belgiojoso et al [5] found that patients
with less severe histologic findings were younger in age and
patients with more generalized lesions always had proteinuria
greater than 1 g124 hr. Morel-Maroger, Leathem, and Richet [41
studied a large sample of patients in France and noted that
progression to chronic renal insufficiency was associated with
severe tubulo-interstitial lesions. In two studies, the presence of
gross hematuria has been associated with a better prognosis.
This was observed by Sissons et al [11] and Imbasciati et al [23].
In our patients, the absence of gross hematuria was associated
with relatively mild histopathologic lesions and absence of
peripheral glomerular capillary wall changes by EM.
In studies comparing the outcome of children and adults with
IgA nephropathy, there appears to be a good agreement that
younger patients have a better prognosis. In one study [261,
males have been found to develop progressive renal failure
more frequently than females. However, the number of patients
involved was small, and this has not been confirmed in other
series. Although in our study we noted no differences in the
clinical outcome of the two sexes, our follow-up has been very
brief. However, there was a significant association between
females and lesser glomerular changes by light microscopy.
Peripheral glomerular capillary wall changes such as splitting,
splintering, and thinning of the glomerular basement membrane
we have noted in patients with IgA nephropathy are character-
istic of hereditary nephropathy. However, similar changes have
been noted focally in a variety of different renal diseases [55, 56]
and, if focal, are not thought to be indicative of hereditary
nephropathy. In our study, none of the patients with such
changes had a positive family history of hereditary nephritis.
Several investigators [39, 44, 47, 57—60] have noted similar focal
changes in the glomeruli of patients with IgA nephropathy,
although few have called specific attention to them. Although
the pathogenesis of the peripheral glomerular capillary wall
changes is uncertain, increased permeability of the peripheral
glomerular capillary wall has been shown to enhance mesangial
uptake of a number of biologically active substances in some
experimental models [61, 621; thus, the capillary wall changes
may lead to increasing mesangial changes and progressive
damage with a worsening in glomerular morphology, function,
and clinical outcome. We found a positive correlation between
the presence of peripheral glomerular capillary wall changes,
degree of proteinuria, and severity of glomerular pattern by
light microscopy. It is possible that these ultrastructural
glomerular capillary wall findings may be a harbinger of a poor
prognosis. However, it must be stressed that the present length
of follow-up of our patients is too short to allow any statement
of the natural history of IgA nephropathy in children. It will be
necessary to evaluate more long-term clinical features to devel-
op clinico-pathologic correlations based on initial pathologic
findings.
The overall prognosis of patients with IgA nephropathy
remains to be confirmed. In adult studies, the incidence of renal
insufficiency varies from less than 10 to 48% in patients
followed for longer than 1 year. In children, the prognosis
appears to be much better [9, 30—341. However, this difference
may well result from the slow progressive nature of the disease.
In the pediatric series reported to date, the incidence of chronic
renal insufficiency appears to be less than 10%. However,
Berger pointed out that a number of patients who have devel-
oped endstage renal disease in early adult life developed their
initial clinical features during childhood [481. We suspect that a
significant proportion of children with IgA nephropathy may
well show progressive renal failure as they enter their third or
fourth decade. This thesis also needs to be studied by long-term
longitudinal studies of patients presenting during childhood.
The treatment of IgA nephropathy has been very unsatisfac-
tory. A limited number of patients have been treated with
tonsillectomy [10, 16] steroids [34], cytoxan [101, and phenytoin
[39]. Of these, various therapeutic regimens, only alternate-day
prednisone, as used by McEnery, McAdams, and West has
been claimed to provide some benefit [32]. In four children
treated by this group, prednisone appeared to improve the
clinical status but this improvement did not persist after the
therapy was discontinued. At the present time, there is no
satisfactory therapy for this disorder. In most of our patients,
there has been no attempt to administer medications. Two
patients were given indomethacin without apparent benefit.
Both of these patients have persistent nephrotic syndrome.
In conclusion, the long-term outlook for children with IgA
nephropathy remains uncertain. The 62 patients presented in
this study will be followed carefully so that a long-term longitu-
dinal study may provide some further information regarding this
disorder.
Acknowledgments
The Southwest Pediatric Nephrology Study Group acknowledges
support from the National Kidney Foundation of Texas, Abbott Labo-
ratories, American Medical Products, American McGaw, Cutter Labs,
E. R. Squibb & Sons, Inc., Travenol, and the Upjohn Company.
Portions of this work were presented at the 14th Annual Meeting of the
American Society of Nephrology, November 1981 (Kidney ml 21:15 la,
1981 and 21:2l3a, 1981). The study group wishes to thank Y. Clark and
A multicenter study of IgA nephropathy in children 651
K. Green for secretarial assistance and N. V. Wilson of the Medical
Computing Resources Center at the University of Texas Health Science
Center at Dallas for programming assistance in statistical data analysis.
Reprint requests to Dr. R. J. Hogg, Southwest Pediatric Nephrology
Study Group Central Office, Room G3.254, University of Texas Health
Science Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas
75235, USA
References
I. BERGER J, HINGLAIS N: Les dépôts intercapillaires d'IgA-IgG. J
Urol Nephrol (Paris) 74:694—695, 1968
2. BERGER J: IgA glomerular deposits in renal disease. Transplant
Proc 1:939—944, 1969
3. DRUET P, BARIETY J, BERNARD D, LAGRUE G: Les glomerulopath-
ies primitives a depots mésangiaux d'IgA et d'IgG. Etude clinique
et morphologique de 52 cas. Presse Med 78:583—587, 1970
4. MOREL-MAROGER L, LEATHEM A, RICHET G: Glomerular abnor-
malities in nonsystemic diseases. Relationship between findings by
light microscopy and immunofluorescence in 433 renal biopsy
specimens. Am J Med 53:170—184, 1972
S. BARBIANO Dl BELoloJoso G, TARANTINO A, CI VAT! G, LIMIDO D,
MINETTI L: Glomerulonefrite a depositi intercapillari di IgA-IgG:
Studio clinico e morfologico di 63 casi. Ric C/in Lab 30 (suppl):52—
62, 1973
6. DEWERRA P, MOREL-MAROGER L, LEROUX-ROBERT C, RICHET G:
Glomérulites a depOts d'IgA diffus dans le mésangium. Etude de 96
cas chez l'adulte. Schwiez Med Wochenschr 103:761—768, 1973
7. LOWANCE DC, MULLINS JD, MCPHAUL JJ: Immunoglobulin A
(IgA) associated glomerulonephritis. Kidney mt 3:167—176, 1973
8. MOREL-MAROGER L, MERY JP, ROBERT CL, RICHET G: Mesangial
IgA deposits, in Glomerulonephritis—Morphology. Natural His-
tory and Treatment, edited by KINCAID-SMITH P. MATHEW TH,
BECKER EL. New York, J. Wiley & Sons, 1973, pp. 301—304
9. McCoy RC, ABRAMOWSKY CR, TI5HER CC: IgA nephropathy. Am
J Pathol 76:123—144, 1974
10. WOODROFFE AJ, THOMSON NM, MEADOWS R, LAWRENCE JR:
IgA-associated glomerulonephritis. Aust NZ J Med5:97—100, 1975
11. SISSONS JGP, WOODROW DF, CURTIS JR, EVANS DJ, GOWER PE,
SLOPER JC, PETERS DK: Isolated glomerulonephritis with mesan-
gial IgA deposits. Br Med J 3:611—614, 1975
12. ZIMMERMAN SW, BURKHOLDER PM: Immunoglobulin A nephrop-
athy. Arch Intern Med 135:1217—1223, 1975
13. FINLAYSON G, ALEXANDER R, JUNCOS L, SCHLEIN E, TEAGUE P,
WALDMAN R, CADE R: Immunoglobulin A glomerulonephritis: A
clinicopathologic study. Lab Invest 32:140—148, 1975
14. DROZ D: Natural history of primary glomerulonephritis with mes-
angial deposits of IgA. Contrib Nephrol 2:150—157, 1976
15. KATZ A, UNDERDOWN BJ, MINTA JO, LEPOW IH: Glomerulone-
phritis with mesangial deposits of IgA unassociated with systemic
diseases. Can Med Assoc J 114:209—215, 1976
16. VAN DER PEET J, ARIsz L, BRENTJENS JRH, MARRINK J, HOEDE-
MAEKER PJ: The clinical course of IgA nephropathy in adults. Clin
Nephrol 8:335—340, 1977
17. JOSHUA H, SHARON Z, GUTGLAS F, ROSENFELD J, BEN-BASSAT M:
IgA-IgG nephropathy: A clinicopathologic entity with slow evolu-
tion and favorable prognosis. Am J Clin Pathol 67:289—295, 1977
18. ALEXANDER F, BARABAS AZ, JACK RGJ: IgA nephropathy. Hum
Pathol 8:173—185, 1977
19. NAKAMOTO Y, A5ANO Y, Doi-i K, FUJIOKA M, IIDA H, KIDA H,
KIBE Y, HATTORI N, TAKEUCHI J: Primary IgA glomerulonephritis
and Schonlein-Henoch purpura nephritis: Clinicopathological and
immunohistological characteristics. Q J Med 188:495—516, 1978
20. NAGY J, BRASCH H, SULE T, HAM0RI A, DEAK G, AMBRUS M: IgA
glomerulonephritis: Mesangial IgA deposition without systemic
signs (Berger's disease). Int Urol Nephrol 11:367—375, 1979
21. HAIt& M, ENDO Y, NIHEI H, HARA 5, FUKUSHIMA 0, MIMURA N:
IgA nephropathy with subendothelial deposits. Virchows Arch
(PatholAnat) 386:249—263, 1980
22. CLARKSON AR, SEYMOUR AE, CHAN YL, THOMPSON AJ, WooD-
ROFFE AJ: Clinical, pathological and therapeutic aspects of IgA
nephropathy, in Progress in Glomeru/onephritis, edited by KIN-
CAID-SMITH P, D'APICE AJF, ATKINS RC. New York, Wiley
Medical Publications, 1979, pp. 247—259
23. IMBASCIATI E, COLASANTI G, BARBIANO DI BELGI0JO5O G, BANFI
G, DURANTE A, RAGNIA, PONTICELLI C, MINETTI L, D'AMICO G:
Long-term follow-up of IgA mesangial deposits glomerulonephritis.
Dialysis Transplant 14:472—477, 1977
24. DOYLE GD, O'DWYER WF, CARMODY M, CAMPBELL F, BROWNE
0: IgA nephropathy—an immunopathological study. Jr J Med Sci
145:292—303, 1976
25. MAINTZ J, ELEMA JD, HENNINGSEN B, BLAKER F, BUNGER P:
Eine sonderform der chronischen glomerulonephritis: IgA-IgG-
Nephropathie. Dtsch Med Wochenschr 97:1527—1533, 1972
26. HOOD SA, VELOSA JA, HOLLEY KE, D0NADI0 JV: IgA-IgG
nephropathy: Predictive indices of progressive disease. Clin Neph-
rol 16:55—62, 1981
27. D'AMICO G, CALA5ANTI G, FERRARIO F, RAGNI A, CANTfJ P: IgA
mesangial deposits glomerulonephritis (Berger's disease) (ab-
stract). Kidney mt 13:33 Ia, 1978
28. SHIRA! T, T0MIN0 Y, SATO M, Y05HIKI T, ITOH T: IgA nephrop-
athy: Clinicopathology and immunopathology. Contr Nephrol
9:88—100, 1978
29. YOKOSHA H, NAGASE M, MAEDA T, KOIDE K: Mesangial IgA
glomerulonephritis: clinicopathological study of 85 cases. Contrib
Nephrol 9:101—110, 1978
30. RoY LP, FISH AJ, VERNIER RL, MICHAEL AF: Recurrent macro-
scopic hematuria, focal nephritis, and mesangial deposition of
immunoglobulin and complement. J Pediatr 82:767—772, 1973
31. LEVY M, BEAUFILS H, GUBLER MC, HABIB R: Idiopathic recurrent
macroscopic hematuria and mesangial IgA-IgG deposits in children
(Berger's disease). C/in Nephrol 1:63—69, 1973
32. MCENERY PT, MCADAMS AJ, WEST CD: Glomerular morphology,
natural history and treatment of children with IgA-IgG mesangial
nephropathy, in Glomerulonephritis—Morphology. Natural His-
tory and Treatment, edited by KINCAID-SMITH P, MATHEW TH,
BECKER EL. New York, J. Wiley & Sons, 1973, pp. 305—323
33. WEISS RA, JODORKOVSKY R, BENNETT R, GREIFER I: Clinical and
histological spectrum of IgA nephropathy in children and adoles-
centS (abstract). Pediatr Res 15:702a, 1981
34. NAKAHARA C, AOSAI F, HASEGAWA 0, ITO H, MATSUO N,
HAJIKANO H, SAKAGUCHI H: IgA nephropathy in children: A
modified view of clinicopathological characteristics (abstract). Pe-
diatrRes 14:995a, 1980
35. MICI-IALK D, WALDHERR R, SEELIG HP, WEBER HP, SCHARER K:
Idiopathic mesangial IgA-glomerulonephritis in childhood. Eur J
Pediatr 134:13—22, 1980
36. SCHWARTZ GJ, HAYCOCK GB, EDELMANN CM, SPITZER A: A
simple estimate of glomerular filtration rate in children derived
from body length and plasma creatinine. Pediatrics 58:259—263,
1976
37. Pt CL, SALINAS-MADRIGAL L, Koss MN: Evaluation of
percutaneous renal biopsy, in Kidney Pathology Decennial, 1966—
1975, edited by SOMMERS SC. New York, Appleton-Century-
Crofts, 1975, pp. 109—163
38. World Health Organization (WHO) Monograph: Renal Disease:
Classification and Atlas of Glomerular Diseases, edited by CHURG
J, Soair LH, with pathologists and nephrologists in 14 countries.
Tokyo, New York, Igako-Shoin Medical Publishers, Inc., 1982
39. NAVAS-PALACIOS JJ, GUTIERREZ-MILLET LV, USERA-SARRAGA G,
GARZON-MARTIN A: IgA nephropathy: An ultrastructual study.
Ultrastruct Path 2:151—161, 1981
40. NOMOT0 Y: Clinicopathological studies in patients with IgA
nephropathy. Keio Igaku 54:341—349, 1977
41. OKA M: IgA nephropathy—A clinicopathologic study. Jpn J Neph-
rol 18:769—792, 1976
42. UEDA Y, SAKAI N, SAITO T, YAMAGATA T, KITASHIMA T, SUZUKI
T, SOMA Y, KAWAMURA K, MITOME T: Nephropathy with mesan-
gial IgA-IgG deposits. Rinsho Kagaku 10:1421—1431, 1974
43. SINNIAH R, JAVIER AR, KU G: The pathology of mesangial IgA
nephritis with clinical correlation. Histopathology 5:469—490, 1981
44. CLARKSON AR, SEYMOUR AE, THOMPSON AJ, HAYNES WDG,
CHAN Y-L, JACKSON B: IgA nephropathy: A syndrome of uniform
morphology, diverse clinical features and uncertain prognosis. Clin
Nephrol 8:459—471, 1977
652 Southwest Pediatric Nephrology Study Group
45. MOATAMED F, ZAWADA El, STINSON JB, RAMIREZ G: Skin biopsy
and IgA-associated glomerulonephritides (abstract). Kidney mt
21:211, 1982
46. KUPOR LR, MULLINS JD, MCPHAUL JJ: Imniunopathologic find-
ings in idiopathic renal hematuria. Arch Intern Med 135:1204—1211,
1975
47. NG WL, CHAN CW, YEUNG CK, HUA SP: The pathology of
primary IgA glomerulonephritis—a renal biopsy study. Pathology
13:137—143, 1981
48. BERGER J: Idiopathic mesangial deposition of IgA, in Nephrology,
edited by HAMBURGER J, CROSNIER J, GRUNFELD JP. New York,
John Wiley & Sons, 1979, pp. 535—541
49. CLARKSON AR, SEYMOUR AE, WOODROFFE AJ, MCKENZIE PE,
CHAN Y-L, WOOTTON AM: Controlled trial of phenytoin therapy in
IgA nephropathy. C/in Nephrol 13:215—218, 1980
50. EVANS Di, WILLIAMS DG, PETERS DK, SissoNs JGP, BOULTON-
JONES JM, OGG CS, CAMERON iS, HOFFBRAND BI: Glomerular
deposition of properdin in Henoch-Schonlein syndrome and idio-
pathic focal nephritis. Br Med J 3:326—328, 1973
51, Tsi CC, GIANGIACOMO J, ZUCKNER J: Dermal IgA deposits in
Henoch-Schonlein purpura and Berger's nephritis. Lancet (l):342—
343, 1975
52. BAART DE LA FAILLE-KUYPER EH, KATER L, KUIJTEN RH,
KOOIKER CJ, WAGENAAR SS, VAN DER ZOUWEN P, D0RH0UT
MEES EJ: Occurrence of vascular IgA deposits in clinically normal
skin of patients with renal disease. Kidney mt 9:424—429, 1976
53. LAGRUE 0, HIRBEC G, FOURNEL M, TNTRAT0R L: Glomeruloneph-
rite mesangiale a dépbts d'IgA: étude des immunoglobulines séri-
ques. J Urol Nephrol 80:385—392, 1974
54. WHITWORTFI JA, LEIBOWITZ S, KENNEDY MC, CAMERON JS,
CHANTLER C: IgA and glomerular disease. C/in Nephrol 3:33—36,
1976
55. HILL GS, JENIS EH, GOODLOE S: The nonspecificity of the
ultrastructural alteration in hereditary nephriti s. Lab Invest 31:516—
532, 1974
56. KOHAUT EC, SINGER DB, NEVELS BK, HILL LL: The specificity
of split renal membranes in hereditary nephritis. Arch Pathol Lab
Med 100:475—479, 1976
57. SAKAI 0, KITAJIMA T, KAWAMURA K, UEDA Y: Clinicopathologi-
cal studies on IgA glomerulonephritis, in Glomerulonephritis. Pro-
ceedings on the International Symposium on Glomerulonephritis —
Progression and Regression, edited by YOSHITOSHI Y. Baltimore,
University Park Press, 1979, pp. 167—179
58. ZOLLINGER HU, MIHATSCH Mi: Renal Pathology in Biopsy, Ber-
lin, Springer—Verlag, 1978
59. BURKHOLDER PM, ZIMMERMAN SW, MOORTHY AV: A clinico-
pathologic study of the natural history of mesangial IgA nephrop-
athy, in Glomerulonephritis. Proceedings on the International
Symposium on Glomerulonephritis — Progression and Regression,
edited by YosHirosui Y, Baltimore, University Park Press, 1979,
pp. 143—166
60. BERNSTEIN J: igA nephropathy—unconimon morphologic features
(abstract). Proc mt Pediair Nephrol Assoc 4th mt Symp, Helsinki,
Finland, 1977, p. 64
61. MICHAEL AF, KEANE WF, RAIJ L, VERNIER RL, MAUER SM: The
glomerular mesangium. Kidney Int 17:141—154, 1980
62. COUSER WG, SALANT DJ: In situ immune complex formation and
glomerular injury. Kidney hit 17:1—13, 1980
